PubMed:10810403 / 400-561 JSON TXT

Annnotations TAB JSON ListView MergeView

Id	Subject	Object	Predicate	Lexical cue
T62	0-11	C032690	denotes	17 beta-HSD
T60	0-11	GO:0004303	denotes	17 beta-HSD
T61	0-11	GO:0047035	denotes	17 beta-HSD
T65	8-11	PR:P35492	denotes	HSD
T67	8-11	PR:000008437	denotes	HSD
T66	8-11	143095	denotes	HSD
T68	43-52	MOP:0000569	denotes	reduction
T71	56-63	4103	denotes	estrone
T69	56-63	CHEBI:17263	denotes	estrone
T70	56-63	D004970	denotes	estrone
T72	56-63	D004970	denotes	estrone
T76	72-81	4083	denotes	estradiol
T73	72-81	CHEBI:16469	denotes	estradiol
T74	72-81	CHEBI:23965	denotes	estradiol
T75	72-81	D004958	denotes	estradiol
T77	72-81	D004958	denotes	estradiol
T80	96-107	C032690	denotes	17 beta-HSD
T78	96-107	GO:0004303	denotes	17 beta-HSD
T79	96-107	GO:0047035	denotes	17 beta-HSD
T83	104-107	PR:P35492	denotes	HSD
T85	104-107	PR:000008437	denotes	HSD
T84	104-107	143095	denotes	HSD
T86	139-148	MOP:0000568	denotes	oxidation

Id	Subject	Object	Predicate	Lexical cue
T3	0-161	DRI_Background	denotes	17 beta-HSD type 1 catalyzes primarily the reduction of estrone (E1) to estradiol (E2), whereas 17 beta-HSD type 2 catalyzes primarily the oxidation of E2 to E1.

Id	Subject	Object	Predicate	Lexical cue
T2	0-161	DRI_Background	denotes	17 beta-HSD type 1 catalyzes primarily the reduction of estrone (E1) to estradiol (E2), whereas 17 beta-HSD type 2 catalyzes primarily the oxidation of E2 to E1.